利尿剂改变良性阵发性位置性眩晕风险——一项人群水平的病例对照研究
基于TriNetX美国协作网络2019至2024年至少一次就诊的患者,按年龄和性别分层开展病例对照研究,比较伴或不伴良性阵发性位置性眩晕(BPPV)者的利尿剂使用情况。结果显示利尿剂使用在BPPV病例组中显著更常见,但不同利尿剂类别在伴或不伴梅尼埃病(MD)的前庭疾病患者中方向不一。作者认为所有利尿剂均可能改变BPPV风险,其影响有利或不利取决于患者病史。
要点
- 普通人群中BPPV病例组的利尿剂使用较对照组显著更常见。
- 前庭疾病患者中噻嗪类和碳酸酐酶抑制剂(CAI)在对照组更常见,袢利尿剂在对照组更少见。
- MD患者中噻嗪类和袢利尿剂在对照组更常见,CAI使用无显著差异。
核心结论
- 所有利尿剂均可能改变BPPV风险,其影响有利或不利取决于患者个体病史。
- 利尿剂的影响可能更直接与其各类药物的疗效相关,而非其具体作用机制。
研究设计与样本
- 病例对照研究,数据来自TriNetX美国协作网络。
- 查询2019至2024年间至少一次医院就诊者,按年龄(18-44、45-64、65+岁)和性别分层,每层再分为伴或不伴BPPV。
- 排除头部外伤、中耳/内耳手术、中枢性眩晕或偏头痛患者。
- 采用卡方分析比较各病例队列与同年龄/性别对照队列的利尿剂使用率和维生素D缺乏率,并在前庭疾病患者及伴/不伴MD患者中重复分层分析。
主要发现
- 普通人群中,病例队列的利尿剂使用较对照队列显著更常见。
- 前庭疾病患者中,噻嗪类和CAI使用在对照队列更常见,袢利尿剂使用在对照队列更少见。
- MD患者中,噻嗪类和袢利尿剂使用在对照队列更常见,CAI使用无显著差异。
- 不伴MD的患者中,CAI使用亦无显著差异,噻嗪类和袢利尿剂使用在对照队列更少见。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to characterize diuretic use among patients with and without benign paroxysmal positional vertigo (BPPV) using a population-level database. STUDY DESIGN: A case-control study. SETTING: TriNetX US Collaborative Network. METHODS: Subjects with ≥1 hospital visit between 2019 and 2024 were queried and stratified by age (18-44, 45-64, and 65+ years) and sex. Each cohort was then divided into those with/without BPPV. Patients with head trauma, middle/inner ear surgery, central vertigo, or migraine were excluded. The prevalence of diuretic use and vitamin D deficiency of each case cohort was compared against the control cohort of the same age/sex using Chi-square analysis. This stratification and analysis were repeated for patients with a vestibular disorder, as well as those with/without Ménière's disease (MD). RESULTS: Diuretic use was significantly more common in case cohorts than in control cohorts in the general population. In vestibular patients, thiazide and carbonic anhydrase inhibitor (CAI) use were more common in control cohorts, and loop use was less common. In MD patients, thiazide and loop use were more common in control cohorts, and CAI use did not differ significantly. In patients without MD, CAI use also did not differ, while thiazide and loop use were less common in control cohorts. CONCLUSION: All diuretics may alter the risk of BPPV. Their influences can be favorable or unfavorable, depending on the individual patient's medical history. Their effects might relate more directly to the efficacy of each diuretic class rather than their specific mechanisms of action.
引用
- Li M, Chiffer RC, Li H, et al. Risk of Benign Paroxysmal Positional Vertigo Modified by Diuretics-A Population-Level Case-Control Study. Otolaryngol Head Neck Surg. 2025. PMID: 40325935. doi:10.1002/ohn.1282
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。